Medical specialists from Canada tagged as investigators in clinical trials studying Scleroderma, Diffuse
Total 9 results
-
Anna SpreaficoSeen in:
- Ontario, Toronto, GSK Investigational Site
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
- Other, Toronto, University Health Network, Princess Margaret Hospital
- Toronto, University Health Network, Princess Margaret Hospital
Trials:- NCT03816345 (Principal Investigator)
- NCT05208762 (Principal Investigator)
- NCT06256588 (Principal Investigator)
Conditions:- Hematopoietic and Lymphoid Cell Neoplasm;
- Malignant Solid Neoplasm;
- Multiple Sclerosis;
- Rheumatoid Arthritis;
- Systemic Lupus Erythematosus;
- Psoriasis;
- Systemic Scleroderma;
- Crohn Disease;
- Ulcerative Colitis;
- Dermatomyositis;
- Psoriatic Arthritis;
- Inflammatory Bowel Disease;
- Autoimmune Disease;
- Sjogren Syndrome;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Gastric Cancer;
- Ovarian Neoplasms;
- Squamous Cell Carcinoma of the Head and Neck;
- Triple Negative Breast Neoplasms;
- Esophageal Squamous Cell Carcinoma;
- Neoplasms, Head and Neck
-
Christian Pineau, MDSeen in:
- Quebec, Montréal, RI-MUHC
Trials:- NCT05007340 (Principal Investigator)
-
Inés Colmegna, MDSeen in:
- Quebec, Montréal, RI-MUHC
- Quebec, Montréal, Research Institute - McGill University Health Centre
Trials:- NCT05236491 (Principal Investigator)
- NCT05007340 (Principal Investigator)
Conditions:- Rheumatoid Arthritis;
- Systemic Lupus Erythematosus;
- Systemic Sclerosis;
- Systemic Vasculitis;
- Immunosuppression;
- Scleroderma;
- Autoimmune Rheumatologic Disease;
- Undifferentiated Connective Tissue Diseases;
- Overlap Connective Tissue Disease;
- Rheumatic Diseases;
- Interstitial Lung Disease;
- Usual Interstitial Pneumonia;
- Nonspecific Interstitial Pneumonia;
- Rheumatic Arthritis;
- Systemic Autoimmune Disease;
- Autoimmune Myositis
-
Janet E PopeSeen in:
- Ontario, London, Rheumatology Clinic, St. Joseph's Health Care
Trials:- NCT03976245 (Principal Investigator)
- NCT05149768 (Principal Investigator)
Conditions: -
Maggie Larche, MDSeen in:
- Ontario, Hamilton, St-Joseph's Healthcare Hamilton
Trials:- NCT05785065 (Principal Investigator)
-
Marie Hudson, MDSeen in:
- Quebec, Montreal, Jewish General Hospital - CIUSSS-COMTL
Trials:- NCT05785065 (Principal Investigator)
-
Sabrina Hoa, MDSeen in:
- Quebec, Montreal, Centre hospitalier de l'Université de Montréal (CHUM)
Trials:- NCT05785065 (Principal Investigator)
-
Silvia Vidal, PhDSeen in:
- Quebec, Montréal, RI-MUHC
Trials:- NCT05007340 (Principal Investigator)
-
Zareen AhmadSeen in:
- Ontario, Toronto, GSK Investigational Site
Trials:- NCT05878717 (Principal Investigator)
Clinical Trials on Scleroderma, Diffuse
-
Lawson Health Research InstituteNovartis PharmaceuticalsTerminated
-
Boston UniversityRegeneron PharmaceuticalsCompletedSystemic Sclerosis | Scleroderma | Diffuse Systemic Sclerosis | Diffuse SclerodermaUnited States
-
Gilead SciencesCompletedDiffuse Scleroderma | Limited SclerodermaAustralia
-
Michael M. PhamTerminatedSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
Northwestern UniversityCompletedSYSTEMIC SCLERODERMAUnited States
-
University of UtahEnrolling by invitationSclerodermaUnited States
-
George Washington UniversityCompleted
-
University of Texas Southwestern Medical CenterCompletedSclerodermaUnited States
-
Cytori TherapeuticsWithdrawn
-
University of California, San FranciscoRoche Pharma AGCompleted